GSDMD and central nervous system cancer: While there is currently a dearth of research on the regulation of glioma pyroptosis by EZH2, our initial experiments demonstrate that treatment with the EZH2 inhibitor DZNep substantially activates the expression of GSDMD in glioma cells, concomitant with an increase in inflammatory factor expression.